Merck Disappointed with Brazil over Patent Breach; India Pharma to Benefit (SeekingAlpha via Yahoo! Finance)

Merck Disappointed with Brazil over Patent Breach; India Pharma to Benefit (SeekingAlpha via Yahoo! Finance)
Brazil’s President broke the patent on Merck’s Efavirenz AIDS drug after a 30% price cut to $1.10/pill came up well short of the government’s desire to having pricing on par with Thailand’s $0.65/pill.